Gestational diabetes mellitus is a common metabolic disorder diagnosed during pregnancy. During pregnancy insulin resistance increases due to placental, growth and progesterone hormones. As pregnancy precedes the insulin resistance increase gradually, making hyperglycemia worse. The main task is to control hyperglycemia during pregnancy to prevent maternal and fetal complications. Initially diet and physical exercise is encouraged otherwise drug management is required. Combination of regular insulin and Metformin is an effective way to control hyperglycemia in gestational diabetes mellitus when diet and moderate exercise alone is ineffective.
Introduction
Gestational diabetes mellitus, according to the world health organization (WHO) is defined as the hyperglycemia recognized during any phase of pregnancy. Statistical data from the worldwide shows that one out of six pregnancies is associated with hyperglycemia of type 2 diabetes mellitus (T2DM). In Asia this figure count is one in four pregnancies [1] [2] . This varies with age of pregnant women. For example, 16 .9% lie in between 20-46 years of age.
Gestational diabetes should be screened be out at 16, , and 30 weeks of pregnancy, respectively by oral glucose tolerance test (OGTT). Oral 75 G glucose after12-14 hours overnight fasting is used. Blood glucose levels are measured after 2 hours. Gestational diabetes is better controlled by dietary restrictions. Insulin remains the first the line of treatment in pregnancy. Regular insulin and NPH are commonly used while the effects of rapid insulin analog (Lispro) are being used while long acting insulin analog (Glargin) is not recommended. Insulin resistance increases progressively throughout pregnancy. Dose requirement increases 0.8-0.9/kg body weight during pregnancy. Recently, oral sulphonylurea (Glyburide) and Biguanide (Metformin) is also being used frequently. The main contributing factor in gestational hyperglycemia is insulin resistance. The likely causes of hyperglycemia are placental hormones and weight gain during pregnancy [3] [4] . Sulphonylurea though bring down the blood glucose level, but it is not helpful to overcome the insulin resistance, rather it depletes pancreatic insulin store and could cause fetal hypoglycemia. Metformin is now frequently used during pregnancy. Metformin helps in maternal weight loss and prevent fatal hypoglycemia [5] [6] [7] . In our study the effects of regular insulin during the first trimester and combination of regular insulin and Metformin in second and third trimester were studied. The pregnant women were mainly treated in gynae and obs OPD and near delivery they were admitted in Mohi-Ud-Din Teaching Hospital Mirpur AJK and affiliated community hospitals from July 2016-December 2016. Total number of, one hundred and forty seven (147), pregnant women were studied.
Aims and objectives
The objective of this study was to find out the safety and effectiveness of regular insulin and Metformin in gestational diabetes mellitus. 
Material and Methods

Inclusion criteria
Gestational diabetic women.
Exclusion criteria
1) Type 1 diabetes mellitus patients 2) Type 2 diabetes mellitus patients 3) Known malignancy, autoimmune and pancreatic diseases.
Study design
Prospective descriptive study. Table 1 shows that total one hundred and forty seven (147) pregnant women were included in the study.
Data analysis
Age Groups Age in years Total Number of pregnant women=147
Group=A
20-30 63
Group=B 31-35 84 Table 3C : Results of glyceamic levels in third trimester after Regular Insulin+Metformin therapy.
In Table 3C , after initiation of Regular Insulin+Metformin therapy in third trimester. Group-A: Fasting and random blood glucose levels during third trimester was reduced to FBG (115 mg/dl), RBG (156 mg/dl). Group-B: Fasting and random blood glucose levels during second trimester was reduced to FBG (118 mg/dl), RBG (161 mg/dl). Table 1 shows the total number of pregnant women included in the study were one hundred and forty seven (147).
Results
Group-A included sixty three (63) and Group-B: Eighty four (84) pregnant women. Most of them were treated and at gynecological and obstructed OPD during the first trimester and second trimester. They were only admitted during last trimester or near labour. From Table 2 , we noted that there was a rising trend of blood glucose during first, second and third trimester of gestational period despite dietary control. This appears to be due to placental hormonal and weight gain. Therapy with Regular Insulin in the first trimester and Regular Insulin+Metformin in second and third trimester were studied. 
Discussion
Gestational diabetes mellitus is a most common metabolic disorder diagnosed during pregnancy [8] [9] [10] . It is important to diagnose and treat it at the earliest stage to prevent maternal and fetal complications. Initially diet and physical exercise is encouraged otherwise drug management is required. In the new strategy, safety and efficacy of Metformin and insulin, during pregnancy is being evaluated. During pregnancy insulin resistance increases due to placental, growth and progesterone hormones. As pregnancy proceeds the insulin resistance increase gradually, family history of diabetes. It is necessary to screen out women before conception, during pregnancy and after delivery for risk of development of diabetes [11] [12] [13] [14] [15] . Screening for diabetes is important, during pregnancy to avoid the maternal and fetal complications. A pregnant woman having blood fasting glucose higher than 126 mg/dl and random blood sugar more than 200 mg/dl is confirmed case of gestational diabetes. Glycated hemoglobin >6.5%
shows pre-existing diabetes. After delivery, when hyperglycemic effects of placental hormones are removed so majority of women return to normal glyceamic state. The subsequent outcome after birth of a child is; 2/3 will have gestational diabetes in the next pregnancy; 20% have impaired glucose tolerance in the postpartum and 50% will have type 2 diabetes mellitus [16] [17] [18] [19] [20] [21] [22] [23] [24] . The most common fetal complications are macrosomia, spontaneous abortion;
congenital malformation and intrauterine death. The most common maternal complications are risk of recurrence of diabetes in future pregnancies, polyhydramnios, toxemia of pregnancy, urinary tract infections, higher incidence of premature birth and cesarean section.
The purpose of treatment is to avoid adverse effects of hyperglycemia during pregnancy. Dietary control includes intake of dietary fibers and fruits and chicken, fish, fruits and vegetables [25] [26] [27] . Vitamin-D deficiency is common [30] . A 75-g oral glucose tolerance test (OGTT) after 1 hour, higher than 180 mg/dl and 75-g oral glucose tolerance test (OGTT) after 2 hours, higher than 150 mg/dl confirm the diagnosis of gestational diabetes. The purpose of treatment is to maintain glyceamic level at normal range. The preprandial blood glucose level should be less than 90 mg/dl. One hour after meal less than 140 mg/dl and two hours after meal less than <120 mg/dl. The women diagnosed as gestational diabetes mellitus must be followed at 02-03 months and screened annually for risk of type 2 diabetes [30-31].
Conclusion
Diagnosis of gestational diabetes mellitus should be according to standard criteria and its treatment during the gestational periods prevents maternal and fetal complications. Prenatal screening is important for the pre diabetic
